|
DCLRE1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.278800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.161900E-03 |
| Normal-vs-Stage2 |
3.657400E-03 |
| Normal-vs-Stage3 |
2.510100E-02 |
| Normal-vs-Stage4 |
6.119500E-03 |
| Stage1-vs-Stage2 |
2.445000E-01 |
| Stage1-vs-Stage3 |
8.210000E-01 |
| Stage1-vs-Stage4 |
5.009600E-01 |
| Stage2-vs-Stage3 |
2.644000E-01 |
| Stage2-vs-Stage4 |
6.817800E-01 |
| Stage3-vs-Stage4 |
4.692000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.773810E-02 |
| Normal-vs-AfricanAmerican |
5.534400E-01 |
| Normal-vs-Asian |
3.012400E-02 |
| Caucasian-vs-AfricanAmerican |
2.880000E-01 |
| Caucasian-vs-Asian |
7.701000E-01 |
| AfricanAmerican-vs-Asian |
2.591600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.644400E-03 |
| Normal-vs-Female |
8.603900E-03 |
| Male-vs-Female |
6.386800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.136120E-02 |
| Normal-vs-Age(41-60Yrs) |
9.582600E-03 |
| Normal-vs-Age(61-80Yrs) |
5.283800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.252200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.948800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.627400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.440200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.455200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.446800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.768600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.520600E-01 |
| Classical-VS-Follicular |
4.45560000006395E-08 |
| Classical-VS-Other |
5.520400E-02 |
| Classical-VS-Normal |
1.147990E-01 |
| Tall-VS-Follicular |
1.004400E-03 |
| Tall-VS-Other |
6.585900E-02 |
| Tall-VS-Normal |
3.384600E-01 |
| Follicular-VS-Other |
9.087800E-01 |
| Follicular-VS-Normal |
2.40919999949796E-07 |
| Other-VS-Normal |
1.074290E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.318830E-03 |
| Normal-vs-N1 |
1.862890E-03 |
| N0-vs-N1 |
3.888400E-01 |
|
|
